The high persistence of substandard drugs and clinically inappropriate artemisinin monotherapies inAfrica risks patient safety and endangers the future of malaria treatment.

The reality is that we simply do not know how efficacious most  drugs really are. 

A significant portion of antimalarial drugs in Africa have been illegally diverted from the public sector, where they were intended to be dispensed free of charge in public health facilities, to the private sector.

Ending the use of DDT in malarious areas may pose great risks to the health and welfare of people and would be based on flawed analysis.

In attempting to ban pesticides, policymakers are overlooking the risk of insect-borne diseases.

The Global Fund is to be commended for its transparency, but it has failed to act on the information it has gleaned, and continues to allow its funds to be used by governmental distribution systems known to be corrupt.

The United States Agency for International Development must change its policy, or its health officials should be replaced by those who will.

The drug regulatory system in India needs to be improved for domestic consumption and because India is an increasingly important exporter of drugs for both developed and developing countries.